Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 9:00 AM ET

Date/Time Source News Release
11/27/2023 06:50 AM EST GlobeNewswire RVL Completes Financial Restructuring
10/12/2023 06:50 AM EDT GlobeNewswire RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
08/23/2023 04:05 PM EDT GlobeNewswire RVL Pharmaceuticals plc to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08/16/2023 08:00 AM EDT GlobeNewswire RVL Pharmaceuticals plc Announces $5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
08/14/2023 06:50 AM EDT GlobeNewswire RVL Pharmaceuticals plc Reports Second Quarter 2023 Financial Results; Provides Update on Strategic Business Review
08/02/2023 08:30 AM EDT GlobeNewswire RVL Pharmaceuticals plc to Discuss Second Quarter 2023 Financial Results and Provide Commercial Update
07/05/2023 06:50 AM EDT GlobeNewswire RVL Pharmaceuticals plc Provides Business Update
06/15/2023 04:15 PM EDT GlobeNewswire RVL Pharmaceuticals plc Announces Result of Proposal to Approve a Waiver of Offer Obligations under Rule 9 of the Irish Takeover Rules at Annual General Meeting
05/11/2023 06:50 AM EDT GlobeNewswire RVL Pharmaceuticals plc Reports First Quarter 2023 Financial Results; Provides Commercial Update
05/04/2023 06:50 AM EDT GlobeNewswire RVL Pharmaceuticals plc to Discuss First Quarter 2023 Financial Results and Provide Commercial Update
Page